US › Healthcare

Scisparc Ltd (SPRC)

US · Healthcare · Biotechnology

$6.74-5.87%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$395,000

Revenue YoY

-56.4%

Net profit

$-2.9M

Profit YoY

-27.2%

EPS

$-6.20

EPS estimate

$0.00

Net margin

-721.8%

Key statistics

Market cap

$4.1M

P/E

0.1

Forward P/E

0.0

P/B

0.93

Book value

$11.60

EPS (TTM)

$98.07

52-week high

$80.10

52-week low

$2.98

50-day MA

$6.69

200-day MA

$10.90

Beta

2.48

Shareholding

Institutions

0.55%

Largest institutional holders

Fund	Stake
UBS Group AG	0.55%
SBI Securities Co Ltd	0.00%
SRS Capital Advisors Inc	0.00%
Strategic Investment Solutions Inc	0.00%
JustInvest LLC	0.00%
XTX Topco Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Scisparc Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.